Home
Search
BIO CEO & Investor Conference   |   February 10-11, 2025

Speakers & Presenters

All Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
James Sapirstein, MBA, PharmD
CHAIRMAN, PRESIDENT AND CEO, FIRST WAVE BIOPHARMA, INC.
First Wave BioPharma, Inc.
Boca Raton, Florida, United States
photo
Anthony Sasse, FRACP
DR, SNORETOX LTD
Snoretox Ltd
Kew, Australia
photo
Dana M. Schmidt
VICE PRESIDENT, LIFE SCIENCES, CHUBB
Building a Resilient Biotech Company: Management Lessons Through Capital Downturns
New York, New York, United States
photo
Sandor Schoichet
CO-FOUNDER AND PARTNER, CO-FOUNDER AND PARTNER, BIOPHARMA SUSTAINABILITY ROUNDTABLE
Investors’ ESG Expectations for Drug Developers
photo
Somasekar Seshagiri
CEO, ANTLERA THERAPEUTICS
AntlerA Therapeutics
Foster City, California, United States
photo
Dhvanit Shah, PhD
PRESIDENT AND CHIEF EXECUTIVE OFFICER, GARUDA THERAPEUTICS
Garuda Therapeutics
Cambridge, Massachusetts, United States
photo
Jennifer Sheng
MANAGING DIRECTOR, CITI
Market Outlook—Convincing Hesitant Investors for IPOs versus Other Capital Alternatives
photo
Scott Shively
PRESIDENT AND CEO, BEXION PHARMACEUTICALS
Bexion Pharmaceuticals, Inc.
Covington, Kentucky, United States
photo
Yaping Shou, MD, PhD
VENTURE PARTNER, LILLY ASIA VENTURES AND CEO, WELLS THERAPEUTICS
Recalculating Risk vs. Opportunity in China Deal-Making
photo
Farrell Simon, PharmD
SVP, HEAD OF COMMERCIAL AND STRATEGY, TREVI THERAPEUTICS
Trevi Therapeutics, Inc.
New Haven, Connecticut, United States
photo
Elizabeth Smith, MBA, PhD
VICE PRESIDENT, BUSINESS DEVELOPMENT, FZATA, INC.
Fzata, Inc.
Halethorpe, Maryland, United States
photo
Ira Spector, PhD
CEO, SFA THERAPEUTICS, INC.
SFA Therapeutics, Inc.
Jenkintown, Pennsylvania, United States
photo
Cindy Steinberg
NATIONAL DIRECTOR OF POLICY & ADVOCACY, US PAIN FOUNDATION
Resetting the innovation landscape for pain and addiction therapeutics
Lexington, Massachusetts, United States
photo
Michael Stiller
NEW INITIATIVES, NASDAQ CAPITAL ACCESS PLATFORMS, NASDAQ
Investors’ ESG Expectations for Drug Developers
photo
Jeff Strovel, PhD
CEO, CONVERGENE
Veralox Therapeutics
Frederick, Maryland, United States
photo
Eddie Sullivan , PhD
CO-FOUNDER, PRESIDENT & CEO, SAB BIOTHERAPEUTICS
SAB Biotherapeutics
Sioux Falls, South Dakota, United States
Load More